Details for New Drug Application (NDA): 022560
✉ Email this page to a colleague
The generic ingredient in ATELVIA is risedronate sodium. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the risedronate sodium profile page.
Summary for 022560
Tradename: | ATELVIA |
Applicant: | Apil |
Ingredient: | risedronate sodium |
Patents: | 3 |
Suppliers and Packaging for NDA: 022560
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATELVIA | risedronate sodium | TABLET, DELAYED RELEASE;ORAL | 022560 | NDA | Allergan, Inc. | 0430-0979 | 0430-0979-03 | 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (0430-0979-03) |
ATELVIA | risedronate sodium | TABLET, DELAYED RELEASE;ORAL | 022560 | NDA AUTHORIZED GENERIC | Greenstone LLC | 59762-0407 | 59762-0407-4 | 1 BLISTER PACK in 1 CARTON (59762-0407-4) / 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 35MG | ||||
Approval Date: | Oct 8, 2010 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 9, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 9, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 16, 2026 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 022560
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apil | ATELVIA | risedronate sodium | TABLET, DELAYED RELEASE;ORAL | 022560-001 | Oct 8, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Apil | ATELVIA | risedronate sodium | TABLET, DELAYED RELEASE;ORAL | 022560-001 | Oct 8, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription